Uniqus Consultech Onboards UST as an Investor, as Part of its Previously Announced Series B Round
Reading Time: 3 minutes Aliso Viejo, Calif., United States & Mumbai, Maharashtra, India: UST, a leading digital transformation solutions company, has invested in Uniqus Consultech, a tech-enabled global platform that offers consulting solutions in the accounting & reporting, finance operations, governance, risk, ESG, and technology
Invest in Bogota Seeks New Investment Opportunities at Bengaluru Tech Summit 2024
Reading Time: 2 minutes From November 19 to 21, Invest in Bogota, the investment promotion agency of Colombia’s capital, will participate in the Bengaluru Tech Summit 2024, one of the world’s leading events for the global tech ecosystem. This year’s summit will feature over 400 speakers, including
BioStock: BiBBInstrument’ founder on the Sahlgrenska evaluation
Reading Time: < 1 minute Tue, Nov 19, 2024 08:15 CET Report this content BiBBInstruments takes another step in the clinical evaluation of EndoDrill GI. Recently, Sahlgrenska University Hospital in Gothenburg joined the growing group of clinics evaluating the instrument. BioStock contacted the
The Ritz-Carlton Leadership Center Announces First Live Virtual Course Offered Globally
Reading Time: 2 minutes Bethesda, Md., United States: Live Virtual Experience Comprises Two-Hour Modules Over Three Consecutive Days: January 13 to 15, 2025 from 8 to 10 pm EST January 14 to 16, 2025 from 9 to 11 am SGT January 14 to 16, 2025
Guidewire Outlines Vision for How Modern Core Platforms will Unlock a New Era of Efficiency and Effectiveness in P&C Insurance
Reading Time: 6 minutes Nashville, Tenn., United States: CONNECTIONS CONFERENCE – Guidewire (NYSE: GWRE) will showcase its commitment to improving risk selection and pricing, indemnity management, and claims efficiency in property and casualty insurance at its annual customer conference, Connections. The event will unveil future
Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization
Reading Time: 3 minutes Oslo, 19 November 2024. Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, today releases its third quarter 2024 results. Lytix achieved substantial progress in its clinical pipeline, progressing towards
Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)
Reading Time: 2 minutes San Francisco, United States: Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024, providing an in-depth analysis of current trends, challenges, and opportunities in SCLC clinical trials
Kährs confirms that the redemption of its outstanding senior secured sustainability linked floating rate bonds 2021/2026 with ISIN SE0017085285 is no longer conditional
Reading Time: 2 minutes Kährs BondCo AB (publ) (the “Company“) hereby refers to its senior secured sustainability linked floating rate bonds 2021/2026 with ISIN SE0017085285 (the “Bonds“) and to the terms and conditions of the Bonds (the “Terms and Conditions“). Reference is further made to
Nomination Committee appointed for Diagonal Bio
Reading Time: 2 minutes Read original Diagonal Bio today announces that the Nomination Committee has been appointed in preparation for the Annual General Meeting (AGM) on May 20, 2025. According to the instruction for the Nomination Committee adopted by the AGM in 2024, the Nomination
#24-395 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market